NFIB is a potential target for estrogen receptor-negative breast cancers.
Moon HG, Hwang KT, Kim JA, Kim HS, Lee MJ, Jung EM, Ko E, Han W, Noh DY.
Moon HG, et al. Among authors: kim ja, kim hs.
Mol Oncol. 2011 Dec;5(6):538-44. doi: 10.1016/j.molonc.2011.08.002. Epub 2011 Aug 8.
Mol Oncol. 2011.
PMID: 21925980
Free PMC article.